These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7785428)

  • 1. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
    Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
    Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease.
    Ogawa T; Inugami A; Fujita H; Hatazawa J; Shimosegawa E; Kanno I; Okudera T; Uemura K; Nagata K
    AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):978-81. PubMed ID: 7611090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.
    Friedland RP; Prusiner SB; Jagust WJ; Budinger TF; Davis RL
    J Comput Assist Tomogr; 1984 Oct; 8(5):978-81. PubMed ID: 6381559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.
    Goldman S; Laird A; Flament-Durand J; Luxen A; Bidaut LM; Stanus E; Hildebrand J; Przedborski S
    Neurology; 1993 Sep; 43(9):1828-30. PubMed ID: 8414042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
    Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
    J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
    Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography in Creutzfeldt-Jakob disease.
    Holthoff VA; Sandmann J; Pawlik G; Schröder R; Heiss WD
    Arch Neurol; 1990 Sep; 47(9):1035-8. PubMed ID: 2204331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation.
    Renard D; Castelnovo G; Collombier L; Thouvenot E; Boudousq V
    Prion; 2017 Nov; 11(6):440-453. PubMed ID: 29099286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease.
    Lu H; Jing D; Chen Y; Cui C; Gao R; Wang L; Liang Z; Chen K; Wu L
    J Alzheimers Dis; 2020; 77(4):1513-1521. PubMed ID: 32925055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional cerebral glucose metabolism in major depressive disorder.
    Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
    Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.
    Grünwald F; Pohl C; Bender H; Hartmann A; Menzel C; Ruhlmann J; Keller E; Biersack HJ
    Ann Nucl Med; 1996 Feb; 10(1):131-4. PubMed ID: 8814717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
    Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease.
    Nagasaka T; Nagasaka K; Ohta E; Shindo K; Takiyama Y; Shiozawa Z; Miyazawa N; Yamasaki N; Mori N; Onda H; Shinohara T
    Clin Nucl Med; 2011 Aug; 36(8):725-7. PubMed ID: 21716034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitracer study in Heidenhain variant of Creutzfeldt-Jakob disease: mismatch pattern of cerebral hypometabolism and perfusion imaging.
    Pichler R; Ciovica I; Rachinger J; Weiss S; Aichner FT
    Neuro Endocrinol Lett; 2008 Feb; 29(1):67-8. PubMed ID: 18283251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy.
    Goffinet AM; De Volder AG; Gillain C; Rectem D; Bol A; Michel C; Cogneau M; Labar D; Laterre C
    Ann Neurol; 1989 Feb; 25(2):131-9. PubMed ID: 2784043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.
    Kim EJ; Cho SS; Jeong BH; Kim YS; Seo SW; Na DL; Geschwind MD; Jeong Y
    Eur J Neurol; 2012 Mar; 19(3):488-93. PubMed ID: 22050286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
    Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome.
    Iinuma K; Yanai K; Yanagisawa T; Fueki N; Tada K; Ito M; Matsuzawa T; Ido T
    Pediatr Neurol; 1987; 3(1):12-8. PubMed ID: 3149469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.
    Matías-Guiu JA; Guerrero-Márquez C; Cabrera-Martín MN; Gómez-Pinedo U; Romeral M; Mayo D; Porta-Etessam J; Moreno-Ramos T; Carreras JL; Matías-Guiu J
    Prion; 2017 May; 11(3):205-213. PubMed ID: 28509609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.